The impact of COVID‐19 in the management of AL amyloidosis and Immunoglobulin Deposition Disease: A single‐center experience-Reference-Cited by-同舟云学术

The impact of COVID‐19 in the management of AL amyloidosis and Immunoglobulin Deposition Disease: A single‐center experience

Published:2020-11-29 Issue:3 Volume:106 Page:340-345
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur. J. Haematol.

Author:

Lee Holly¹^ORCID,Tay Jason¹²,Duggan Peter¹,McCulloch Sylvia¹,Neri Paola¹²,Bahlis Nizar J.¹²,Jimenez‐Zepeda Victor H.¹²^ORCID

Affiliation:

1. Department of Medical Oncology and Hematology Tom Baker Cancer Center Calgary AB Canada

2. Charbonneau Cancer Research Institute Calgary AB Canada

Publisher

Wiley

Subject

Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ejh.13552

Reference26 articles.

1. WHO.WHO Coronavirus Disease (COVID‐19) Dashboard[Internet].20202020 November 3 [cited 2020 November 3]; Available from:https://covid19.who.int/

2. Canada Go.Coronavirus disease (COVID‐10): Outbreak update[Internet].20202020 July 20 [cited 2020 November 3]; Available from:https://www.canada.ca/en/public‐health/services/diseases/2019‐novel‐coronavirus‐infection.html

3. Alberta Go.Population statistics.20202020 November 3 [cited 2020 November 3]; Available from:https://www.alberta.ca/population‐statistics.aspx

4. Alberta Go.COVID‐19 Alberta statistics.20202020 November 3 [cited 2020 November 3]; Available from:https://www.alberta.ca/stats/covid‐19‐alberta‐statistics.htm

5. Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. the COVID-19 pandemic breast cancer consortium

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19 Infection and Vaccination and Its Relation to Amyloidosis: What Do We Know Currently?;Vaccines;2023-06-24

2. State-of-the-art review on AL amyloidosis in Western Countries: Epidemiology, health economics, risk assessment and therapeutic management of a rare disease;Blood Reviews;2023-05

3. Daratumumab in AL amyloidosis;Blood;2022-12-01

4. Understanding real‐world treatment patterns and clinical outcomes in AL amyloidosis patients diagnosed in Canada: A population‐based cohort study;eJHaem;2022-09-05